维普中文期刊产品整合服务
35篇 您的检索式:作者名="Ching CL"
    题名 作者 年代 出处 被引量
1High-intensity focused ultrasound ablation:An effective bridging therapy for hepatocellular carcinoma patients显示文摘AIM:To analyze whether high-intensity focused ultrasound(HIFU) ablation is an effective bridging therapy for patients with hepatocellular carcinoma(HCC).METHODS:From January 2007 to December 2010,49 consecutive HCC patients were listed for liver transplantation(UCSF criteria).The median waiting time for transplantation was 9.5 mo.Twenty-nine patients received transarterial chemoembolization(TACE) as a bringing therapy and 16 patients received no treatment before transplantation.Five patients received HIFU ablation as a bridging therapy.Another five patients with the same tumor staging(within the UCSF criteria) who received HIFU ablation but not on the transplant list were included for comparison.Patients were comparable in terms of Child-Pugh and model for end-stage liver disease scores,tumor size and number,and cause of cirrhosis.RESULTS:The HIFU group and TACE group showed no difference in terms of tumor size and tumor number.One patient in the HIFU group and no patient in the TACE group had gross ascites.The median hospital stay was 1 d(range,1-21 d) in the TACE group and two days(range,1-9 d) in the HIFU group(P < 0.000).No HIFU-related complication occurred.In the HIFU group,nine patients(90%) had complete response and one patient(10%) had partial response to the treatment.In the TACE group,only one patient(3%) had response to the treatment while 14 patients(48%) had stable disease and 14 patients(48%) had progressive disease(P = 0.00).Seven patients in the TACE group and no patient in the HIFU group dropped out from the transplant waiting list(P = 0.559).CONCLUSION:HIFU ablation is safe and effective in the treatment of HCC for patients with advanced cirrhosis.It may reduce the drop-out rate of liver transplant candidate.Tan To Cheung Sheung Tat Fan See Ching Chan Kenneth SH Chok Ferdinand SK Chu Caroline R Jenkins Regina CL Lo James YY Fung Albert CY Chan William W Sharr Simon HY Tsang Wing Chiu Dai Ronnie TP Poon Chung Mau Lo 2013World Journal of Gastroenterology2013,19,20:23
2High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation显示文摘The scarcity of liver grafts in Asia leads to a significant dropout of patients from liver transplant waiting lists, particularly patients with hepatocellular carcinoma and a low model for end-stage liver disease score. In order to reduce dropping out, different bridging therapies are employed. We report the use of high-intensity focused ultrasound ablation as a bridging therapy for a patient with hepatocellular carcinoma of stage two and an extremely low platelet count (20×10 9 /L). The ablation was successful. Blood tests showed that his liver function was similar before and after the treatment. No adhesion was encountered in the liver transplantation performed six months later.Tan To Cheung Kenneth SH Chok Regina CL Lo William W Sharr See Ching Chan Ronnie TP Poon Sheung Tat Fan Chung Mau Lo 2012Hepatobiliary & Pancreatic Diseases International2012,11,5:3
3Lamivudine is effective in suppres sing Hepatitis B virus DNA in Chinese hepatitis B surface antigen carries: A pla cebo-controlled trial显示文摘Lai CL Ching CK Tung AKM 1977Hepatol1977,25,1:1
4Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers:a placebo-controlled trial显示文摘Lai CL Ching CK Tung AK 1997Hepatology1997,25,:1
5Risk factors for post-ERCP pancreatitis:a prospective multicenter study显示文摘Ching CL Sherman S Watkins JL 2006Am J Gs-troenterol2006,101,:1
6Cytotoxieity of three dentin bonding agents on human dental pulp cells显示文摘Ruey SC Ching CL Wan YT 2003J Dent2003,31,3:1
7The incidence of ve- nous thromboembolism in cervical cancer: a nationwide population-based study 显示文摘Shiang JT Ying XR Ching CL 2012BMC ReSearch Notes2012,5,1:1
8Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controUed trial 显示文摘Lai CL Ching CK Tung AK 1997Hepatology1997,25,1:1
9Transpedicle body augmenter in painful osteoporotic compression fractures显示文摘Kung CL Anna FYL Ching HH 0,,:1
10Knowledge Value Chain显示文摘Ching CL Jie Y 2000Journal of Man-agement Development2000,19,9:1
11Bargaining and search with recall: a two- period model with complete information 显示文摘Ching CL 1994Operations Re- search1994,42,:1
12Lamivuding is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial显示文摘Lai CL Ching CK Tung AKM 1997Hepatology1997,25,1:1
13Lamivudine is effective in suppressing hepatitis B virus B virus DNA in Chinese hepatitis B surface antigen carriers:A placebocon-trolled trial显示文摘Lai CL Ching CK Tung AKM 1999Hepatogy1999,25,:1
14Acute fatty liver in pregnancy in the UK显示文摘Ching CL Kingham JG Morgan M 2009Gut2009,58,3:1
15Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: aplacebo-controlled trial显示文摘Lai CL Ching CK Tung AKM 1997Heatology1997,25,:1
16Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carrier: a placebo-controlled trial显示文摘 Ching CK Tang AKM 1997Hepatology1997,25,1:1
17LamIvudine is effective in suppressing hepatitis B Virus DNA in Chinese hepatitis B surface antigen carriers:A placebo-controlled trial显示文摘Left CL Ching CK Tung AKM 1997Hepatology1997,25,:1
18Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo -controlled trial显示文摘Lai CL Ching CK Tung AK 1997Hepatology1997,25,1:1
19Prospective study of liver dysfunction in pregnancy in Southwest Wales显示文摘Ching CL Morgan M Hainsworth I etal 2002Gut2002,51,6:1
20Chinese version of the OSI:A validation study显示文摘Lu L Cooper CL Yen Ching 1997Work Stress1997,11,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费